Connect Biopharma Holdings (CNTB) Return on Equity (2024 - 2025)
Connect Biopharma Holdings' Return on Equity history spans 2 years, with the latest figure at 0.78% for Q3 2025.
- For Q3 2025, Return on Equity fell 71.0% year-over-year to 0.78%; the TTM value through Sep 2025 reached 0.78%, down 71.0%, while the annual FY2024 figure was 0.16%, N/A changed from the prior year.
- Return on Equity for Q3 2025 was 0.78% at Connect Biopharma Holdings, down from 0.58% in the prior quarter.
- Across five years, Return on Equity topped out at 0.06% in Q3 2024 and bottomed at 0.78% in Q3 2025.